Dietary soy isoflavone-aglycone lowers food intake in female rats with and without ovariectomy

Obesity

Volumn 16, Issue 2, 2008, Pages 290-297

  Kishida, Taro ^a   Mizushige, Takafumi ^a   Ohtsu, Yohhei ^a   Ishikawa, Shimpei ^a   Nagamoto, Manabu ^a   Izumi, Tohru ^b   Obata, Akio ^b   Ebihara, Kiyoshi ^a  

^a EHIME UNIVERSITY   (Japan)

^b Research Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCAN; ESTRADIOL; ISOFLAVONE DERIVATIVE; SOY ISOFLAVONE AGLYCONE; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; BODY WEIGHT; COMPARATIVE STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; EATING; EPIDIDYMIS; FEMALE; MALE; OVARIECTOMY; PATHOLOGY; RAT; SEXUAL DEVELOPMENT; SPRAGUE DAWLEY RAT; UTERUS;

ANIMALS; BETA-GLUCANS; BODY WEIGHT; DIETARY SUPPLEMENTS; EATING; EPIDIDYMIS; ESTRADIOL; FEMALE; ISOFLAVONES; MALE; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; SEX CHARACTERISTICS; UTERUS;

ANIMALIA; RATTUS;

EID: 39449133736     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2007.68     Document Type: Article

References (38)

1. Lyons PM, Truswell AS, Mira M, Vizzard J, Abraham SF. Reduction of food intake in the ovulatory phase of the menstrual cycle. Am J Clin Nutr 1989;49:1164-1168.
2. Gong EJ, Garrel D, Calloway DH. Menstrual cycle and voluntary food intake. Am J Clin Nutr 1989;49:252-258.
3. Parker GC, McKee ME, Bishop C, Coscina DV. Whole-body metabolism varies across the estrous cycle In Sprague-Dawley rats. Physiol Behav 2001;74:399-403.
4. Geary N. Estradiol, CCK and satiation. Peptides 2001;22:1251-1263.
5. Wade GN. Some effects of ovarian hormones on food intake and body weight in female rats. J Comp Physiol Psychol 1975;88:183-193.
6. Geary N, Asarian L. Cyclic estradiol treatment normalizes body weight and test meal size in ovariectomized rats. Physiol Behav 1999;67:141-147.
7. Geary N, Asarian L, Korach KS, Pfaff DW, Ogawa S. Deficits in E2-dependent control of feeding, weight gain, and cholecystokinin satiation In ER-alpha null mice. Endocrinology 2001;142:4751-4757.
8. Adlercreutz H, Mazur W. Phyto-oestrogens and Western diseases. Ann Med 1997:29:95-120.
9. Messina MJ. Legumes and soybeans: overview of their nutritional profiles and health effects. Am J Clin Nutr 1999;70(3 Suppl):439S-450S.
10. Kurzer MS, Xu X. Dietary phytoestrogens. Annu Rev Nutr 1997;17:353-381.
11. Barnes S. The chemopreventive properties of soy isoflavonoids In animal models of breast cancer. Breast Cancer Res Treat 1997;46:169-179.
12. Messina MJ, Loprinzi CL. Soy for breast cancer survivors: a critical review of the literature. J Nutr 2001;131 (11 Suppl):3095S-3108S.
13. Santell RC, Kieu N, Helferich WG. Genistein inhibits growth of estrogen-independent human breast cancer cells In culture but not in athymic mice. J Nutr 2000:130:1665-1669.
14. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW Jr. Soy protein and isoflavones: their effects on blood lipids and bone density In postmenopausal women. Am J Clin Nutr 1998;68:1375S-1379S.
15. Uesugi T, Toda T, Tsuji K, Ishida H. Comparative study on reduction of bone loss and lipid metabolism abnormality In ovariectomized rats by soy isoflavones, daidzin, genistin, and glycitin. Biol Pharm Bull 2001;24:368-372.
16. Picherit C, Dalle M, Neliat G, Lebecque P, Davicco MJ, Barlet JP, Coxam V. Genistein and daidzein modulate in vitro rat uterine contractile activity. J Steroid Biochem Mol Biol 2000;75:201-208.
17. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998;139:4252-4263.
18. Gutendorf B, Westendorf J. Comparison of an array of in vitro assays for the assessment of the estrogenic potential of natural and synthetic estrogens, phytoestrogens and xenoestrogens. Toxicology 2001;166:79-89.
19. Setchell KD, Brown NM, Desal P, Zimmer-Nechemias L, Wolfe BE, Brashear WT, Kirschner AS, Cassidy A, Heubi JE. Bioavailability of pure isoflavones In healthy humans and analysis of commercial soy isoflavone supplements. J Nutr 2001;131 (4 Suppl):1362S-1375S.
20. Mäkela SI, Pylkkänen LH, Santti RSS, Adlercreutz H. Dietary soybean may be antiestrogenic in male mice. J Nut 1995;125:437-445.
21. Manach C, Regerat F, Texier O, Agullo G, Demigne C, Remesy C. Bioavailability, metabolism and physiological impact of 4-oxo-flavonoids. Nutr Res 1996;19:517-544.
22. Yasuda T, Mizunuma S, Kano Y, Saito K, Oshawa K. Urinary and biliary metabolites of genistein In rats. Biol Pharm Bull 1996;19:413-417.
23. Hutchins AM, Lampe JW, Martini MC, Campbell DR, Slavin JL. Vegetables, fruits, and legumes: effect on urinary isoflavonoid phytoestrogen and lignan excretion. J Am Diet Assoc 1995;95:769-774.
24. Folch J, Lees M, Sloanestanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957;226:497-509.
25. Janning R Schuhmacher US, Upmeier A, Diel R Michna H, Degen GH, Bolt HM. Toxicokinetics of the phytoestrogen daldzein in female DA/Han rats after single i.v. and oral application. Arch Toxicol 2000;74:421-430.
26. Muthyala RS, Ju YH, Sheng S, Williams LD, Doerge DR, Katzenellenbogen BS, Helferich WG, Katzenellenbogen JA. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorg Med Chem 2004;12:1559-1567.
27. Santell RC, Chang YC, Nair MG, Helferich WG. Dietary genistein exerts estrogenic effects upon the uterus, mammary gland and the hypothalamic/pitultary axis in rats. J Nutr 1997;127:263-269.
28. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW Jr. Soy protein and isoflavones: their effects on blood lipids and bone density In postmenopausal women. Am J Clin Nut 1998;68:1375S-1379S.
29. Uesugi T, Toda T, Tsuji K, Ishida H. Comparative study on reduction of bone loss and lipid metabolism abnormality In ovariectomized rats by soy isoflavones, daidzin, genistin, and glycltin. Biol Pharm Bull 2001;24:68-372.
30. Gao G, Herbert Z, Kong J, Gabrielson N, Mautz A, Wu D, Jirikowski GF, Caldwell JD. Estradiol control of expression and levels of estradiol-binding proteins in the medial preoptic area, medial hypothalamus and pituitary. Neuroendocrinology 2003;78:61-71.
31. Zhou W, Cunningham KA, Thomas ML, Estrogen regulation of gene expression in the brain: a possible mechanism altering the response to psychostimulants In female rats. Brain Res Mol Brain Res 2002;100:75-83.
32. Diel R Tissue-specific estrogenic response and molecular mechanisms. Toxicol Lett 2002;127:217-224.
33. Rollerova E, Urbancikova M. Intracellular estrogen receptors, their characterization and function (Review). Endocr Regul 2000;34:203-218.
34. Bayer T, Colnot T, Dekant W. Disposition and biotransformation of the estrogenic isoflavone daidzein In rats. Toxicol Sci 2001;62:205-211.
35. De Beun R, Jansen E, Smeets MA, Niesing J, Slangen JL, van de Poll NE. Estradiol-induced conditioned taste aversion and place aversion In rats: sex- and dose-dependent effects. Physiol Behav 1991;50:995-1000.
36. Peeters BW, Smets RJ, Broekkamp CL. Sex steroids possess distinct stimulus properties in female and male mice. Brain Res Bull 1992;28:319-321.
37. Nogowski L, Mackowiak P, Kandulska K, Szkudelski T, Nowak KW. Genistein-induced changes in lipid metabolism of ovariectomized rats. Ann Nut Metab 1998;42:360-366.
38. Greenberg JA, Boozer CN. The leptin-fat ratio is constant, and leptin may be part of two feedback mechanisms for maintaining the body fat set point in non-obese male Fischer 344 rats. Horm Metab Res 1999;31:525-532.